Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers

Bioconjugate Chemistry

Volumn 10, Issue 4, 1999, Pages 638-646

  Caliceti, Paolo ^a   Schiavon, Oddone ^a   Veronese, Francesco M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED POLYMERS; ENZYMES; ETHYLENE GLYCOL; PHARMACOKINETICS; POLYOLS; RESIDENCE TIME DISTRIBUTION;

AMPHIPHILIC POLYMERS; BIODISTRIBUTIONS; BIOPHARMACEUTICALS; COVALENT BINDING; NEUTRAL POLYMERS; POLY-N-VINYLPYRROLIDONE; POLYMER-PROTEIN CONJUGATES; PROPERTY; SIMILAR NUMBERS; URICASE;

POLYETHYLENE GLYCOLS;

ANIMALIA; CANDIDA;

EID: 0033167240     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc980155k     Document Type: Article

References (47)

1. Delgado, C., Francis, G. E., and Fisher, D. (1992) The uses and properties of PEG-linked proteins. Crit. Rev. Ther. Drugs Carrier Syst. 9, 249-304.
2. Veronese, F. M., Caliceti, P., Schiavon, O., and Sartore, L. (1991) In Poly(ethylene glycol): chemistry, biochemical and biomedical applications (J. M. Harris, Ed.) Plenum Publication Corp., New York.
3. Kartre, K. (1993) The conjugation of proteins with poly(ethylene glycol) and other polymers. Adv. Drug Deliv. Rev. 10, 91-114.
4. Caliceti, P., Schiavon, O., Hirano, T., Ohashi, S., and Veronese, F. M. (1996) Modification of physicochemical and biopharmaceutical properties of superoxide dismutase by conjugation to the polymer of divinyl ether and maleic anhydride. J. Controlled Release 39, 27-34.
5. Ito, Y., Kotoura, M., Chung, D. J., and Imanishi, Y. (1993) Bioconjugate Chem. Trypsin modification by vinyl polymers with variable solubilities that responses to external signals, 4, 358-361.
6. In Neocarzinostatin: the past, present and future of an anticancer drug (1997) (H. Maeda, K. Edo, and N. Ishida, Eds.) Spinger-Verlag, Tokyo.
7. Poznasky, M. J., Halford, J., and Taylar, D. (1988) Growth hormonealbumin conjugates reduced renal toxicity and altered clearance. FEBS Lett. 239, 18-22.
8. Wileman, T. E. (1991) Properties of asparaginase-dextran conjugates. Adv. Drug Del. Rev. 6, 167-180.
9. Von Specht, B. W., and Brendel, W. (1977) Preparation and properties of trypsin and chymotrypsin coupled covalently to poly(N-vinylpyrrolidone). BBA, 484, 109-114.
10. Kakimoto, K., Kojima, Y., Ishii, K., Onoue, K., and Maeda, H. (1993) The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice. Clin. Exp. Immunol. 94, 241-246.
11. Garman, A. J., and Kalindjian, S. B. (1987) The preparation and properties of novel reversible polymer-protein conjugates 2-omegamethoxypolyethylene (5000) glycoxymethylene-3-methylmaleyl conjugates of plasminogen activators. FEBS Lett. 223, 361-365.
12. Bagshawe, K. D. (1994) Antibody-directed enzyme prodrug therapy (Adept). J. Controlled Release 28, 187-193.
13. Rensen, P. C. N., Devrueh, R. L. A., and Vanberkel, T. J. C. (1996) Targeting hepatitis B therapy to the liver: clinical pharmacokinetic considerations. Clin. Pharmacokinet. 31, 131-155.
14. Takakura, Y., and Hashida, M. (1996) Macromolecular carrier systems for targeted drug delivery: pharmacokinetic consideration on biodistribution. Pharm. Res. 13, 820-831.
15. 111In-labeled uricase conjugated with charged dextrans and poly(ethylene glycol). J. Pharmacobio-Dyn. 14, 623-629.
16. Ekrami, H., Kennedy, A. R., and Shen, W-C. (1995) Disposition of positively charged Bowman-Birk protease inhibitor conjugates in mice: influence of protein conjugate charge density and size on lung targeting. J. Pharm. Sci. 84, 456-461.
17. Bogdanov, A. A., Jr., Martin, C., Bogdanova, A. V., Brady, T. J., and Weissleder, R. (1996) An adduct of cis-diamminedichloroplatinum (II) and poly(ethylene glycol) poly(L-lysine)-succinate synthesis and cytotoxic properties. Bioconjugate Chem. 7, 144-149.
18. Takakura, Y., Fujita, T., Hashida, M., and Sezaki, H. (1990) Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 7, 339-346.
19. Oda, T., Akaike, T., Hamamoto, S., Fujio, S., Hirano T., and Maeda, H. (1989) Oxygen radicals in influnza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244, 974-976.
20. Yamaoka, T., Tabata, Y., and Ikada, Y. (1995) Comparison of body distribution of poly(vinyl alcohol) with other water-soluble polymers after intravenous administration. J. Pharm. Pharmacol. 47, 479-486.
21. Yamaoka, T., Tabata, Y., and Ikada, Y. (1995) Fate of water-soluble polymers administered via different routes. J. Pharm. Sci. 50, 349-354.
22. Tabata, Y., Murakami Y., and Ikada, Y. (1998) Tumor accumulation of poly(vinyl alcohol) of different size after intravenous injection. J. Controlled Release 50, 123-133.
23. Yamaoka, T., Tabata, Y., and Ikada, Y. (1994) Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J. Pharm. Sci. 83, 601-606.
24. Seale, S., Love, W. G., Amos, N., Williams, B. D., and Kellaway, I. W. (1992) Accumulation of poly(vinylpyrrolidone) within the inflamed paws of adjuvant arthritic rats. J. Pharm. Pharmacol. 44, 10-14.
25. Pimm, M. V., Perkins, A. C., Strohalm, J., Ulrich, K., and Duncan, R. (1996) Gamma scintigraphy of a 123I-labeled N-(2-hydroxypropyl)methacrylamide. J. Drug Target. 3, 385-390.
26. Kwon, G. S., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K. (1993) Biodistribution of micelle-forming polymer-drug conjugates. Pharm. Res. 10, 970-974.
27. Munniksama, J., Noteborn, N., Kooistra, T., Steinstra, S., Bouma, J. M. W., Gruber, M., Brouwer, A., Dalenand, D. P. U., and Knook, D. L. (1980) Fluid endocytosis by rat liver and spleen. Biochem. J. 192, 613-621.
28. Caliceti, P., Schiavon, O., Mocali, A., and Veronese, F. M. (1989) Evaluation of monomethoxypoly(ethylene glycol) derivatized superoxide dismutase in blood and evidence for its binding to blood cells. Farmaco 44, 711-720.
29. Beckman, J. S., Minor, R. L., White, C. W., Repine, J. E., Rosen, G. M., and Freeman, B. A. (1988) Superoxide dismutase and catalase conjugated to poly(ethylene glycol) increases endothelial enzyme activity and oxidant resistance. J. Biol. Chem. 263, 6884-6892.
30. Kojima, Y., and Maeda, H. (1993) Evaluation of poly(vinyl alcohol) for protein tailoring: improvements in pharmacokinetic properties of superoxide dismutase. J. Bioact. Compat. Polym. 8, 115-131.
31. Brenner, B. M., Hostetter, T. H., and Humes, H. D. (1978) Glomerular permselectebility: barrier function based on discrimination of molecular size and charge. Am. J. Physiol. 234, F455-F460.
32. Barrowcliffe, M. P, Zanelli, G. D., Ellison, D., and Jones, J. G. (1990) Clearance of charged and uncharged dextrans from normal and injured lungs. J. Appl. Physiol. 68, 341-347.
33. Przybylski, M., Fell, E., and Ringsdorf, H. (1978) Synthesis and characterization of polymeric derivatives of the antitumour agent methotrexate. Makromol. Chem. 179, 1791-1733.
34. Yasuda, Y., Fujita, T., Takakura, Y., Hashida, M., and Sezaki, H. (1990) Biochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and poly(ethylene glycol). Chem. Pharm. Bull. 38, 2053-2056.
35. Chuna, C. C., Greenberg, M. L., Viau, A. T., Nucci, M., Brenckman, W. D., and Hershfield, M. S. (1988) Use of poly(ethylene glycol)-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma. Ann. Int. Med. 109, 114-117.
36. Sartore, L., Caliceti, P., Schiavon, O., and Veronese, F. M. (1991) Enzyme modification by MPEG with an amino acid or peptide as space arms. Appl. Biochem. Biotechnol. 27, 45-54.
37. Monfardini, C., Schiavon, O., Caliceti, P., Morpurgo, M., Harris, J. M., and Veronese, F. M. (1995) A branched monometoxypoly(ethylene glycol) for protein modification. Bioconjugate Chem. 6, 62-69.
38. Sartore, L., Ranucci, E., Ferruti, P., Caliceti, P., Schiavon, O., and Veronese, F. M. (1994) Low molecular weight end-functionalized PVP(N-vinylpyrrolidone) for the modification of polypeptide amino groups. J. Bioact. Compat. Polym. 9, 411-428.
39. Ranucci, E., Spagnoli, G., Sartore, L., Ferruti, P., Caliceti, P., Schiavon, O., and Veronese, F. M. (1994) Synthesis and macromolecular weight characterization of low molecular weight end-functionalized poly(4-acryloilmorpholine). Macromol. Chem. Phys. 195, 3469-3479.
40. Sims, G. E. C., and Snape, T. J. (1980) A method for estimation of poly(ethylene glycol) in plasma protein fractions. Anal. Biochem. 107, 60-63.
41. Mahler, H. R. (1963) In The Enzymes (P. D. Boyer, Ed.) Vol III, 2nd ed., Academic Press, New York.
42. Gornall, A G., Bardawill, C. J., and David, M. M. (1949) Determination of serum protein by means of biuret reaction. J. Biol. Chem. 177, 751-766.
43. Habeeb, A. F. S. A. (1966) Determination of free amino groups in proteins by trinitrobenzensulfonic acid. Anal. Biochem. 14, 328-336.
44. Schiavon, O., Caliceti, P., and Veronese, F. M., Uricase modification with amphiphilic polymers. Farmaco (in press).
45. Caliceti, P., Schiavon, O., Morpurgo, M., and Veronese, F. M. (1995) Physisco-chemical and biological properties of monofunctional hydroxy terminating poly(N-vinylpyrrolidone) conjugated superoxide dismutase. J. Bioact. Compat. Polym. 10, 103-120.
46. Morpurgo, M., Schiavon, O., Caliceti, P., and Veronese, F. M. (1996) Covalent modification of mushroom tyrosinase with different amphiphilic polymers for pharmaceutical and biocatalysis applications. Appl. Biochem. Biotechnol. 56, 59-72.
47. Veronese, F. M., Caliceti, P., Schiavon, O., Scrawen, M. D., and Beer, D. (1997) Branched and linear poly(ethylene glycol): influence of the polymer structure on enzymological, pharmacokinetic and immunological properties of protein conjugates. J. Bioact. Compat. Polym. 12, 196-207.